KEGG   PATHWAY: hsa04936
Entry
hsa04936                    Pathway                                
Name
Alcoholic liver disease - Homo sapiens (human)
Description
Alcoholic liver disease (ALD) refers to the damages to the liver and its functions due to alcohol overconsumption. It ranges from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Alcohol consumption promotes liver inflammation by increasing the translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells to produce TNF-alpha through the LPS/Toll like receptor (TLR) 4 pathways. TNF-alpha induces hepatocellular damage. When alcohol intake is chronic and heavy, steatosis is caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which are responsible for fatty acid oxidation and export via ACC and CPT-1. The blockade of AMPK also leads to overexpression of SREBP-1, resulting in an increase of de novo lipogenesis. Moreover, excessive intracellular ROS production induced by ethanol and its metabolite have a critical role in ethanol-induced apoptosis, which may be the critical process in the exacerbation of ALD. It is inferred that the apoptotic signal derived from ROS that was produced by NOX, is mainly transduced through the JNK and p38 MAPK pathways.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
hsa04936  Alcoholic liver disease
hsa04936

Disease
H02516  Alcoholic liver disease
Drug
D12391  Denifanstat (USAN/INN)
Organism
Homo sapiens (human) [GN:hsa]
Gene
10000  AKT3; RAC-gamma serine/threonine-protein kinase isoform 1 [KO:K04456] [EC:2.7.11.1]
100293534  C4B_2; complement C4-B-like preproprotein [KO:K03989]
10454  TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 isoform alpha [KO:K04403]
10645  CAMKK2; calcium/calmodulin-dependent protein kinase kinase 2 isoform 1 [KO:K07359] [EC:2.7.11.17]
10891  PPARGC1A; peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform 2 [KO:K07202]
110384692  C4A_2; complement C4A (Rodgers blood group)-like preproprotein [KO:K03989]
114609  TIRAP; toll/interleukin-1 receptor domain-containing adapter protein isoform a [KO:K05403]
1147  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform 1 [KO:K04467] [EC:2.7.11.10]
124  ADH1A; alcohol dehydrogenase 1A [KO:K13951] [EC:1.1.1.1]
125  ADH1B; all-trans-retinol dehydrogenase [NAD(+)] ADH1B isoform 1 [KO:K13951] [EC:1.1.1.1]
126  ADH1C; alcohol dehydrogenase 1C [KO:K13951] [EC:1.1.1.1]
126129  CPT1C; palmitoyl thioesterase CPT1C isoform 2 [KO:K19524] [EC:2.3.1.21]
127  ADH4; all-trans-retinol dehydrogenase [NAD(+)] ADH4 isoform 2 [KO:K13980] [EC:1.1.1.1]
128  ADH5; alcohol dehydrogenase class-3 [KO:K00121] [EC:1.1.1.284 1.1.1.1]
130  ADH6; alcohol dehydrogenase 6 isoform 2 [KO:K13952] [EC:1.1.1.1]
131  ADH7; all-trans-retinol dehydrogenase [NAD(+)] ADH7 isoform 2 [KO:K13951] [EC:1.1.1.1]
1374  CPT1A; carnitine O-palmitoyltransferase 1, liver isoform isoform 1 [KO:K08765] [EC:2.3.1.21]
1375  CPT1B; carnitine O-palmitoyltransferase 1, muscle isoform isoform a [KO:K19523] [EC:2.3.1.21]
1432  MAPK14; mitogen-activated protein kinase 14 isoform 2 [KO:K04441] [EC:2.7.11.24]
148022  TICAM1; TIR domain-containing adapter molecule 1 isoform 1 [KO:K05842]
1499  CTNNB1; catenin beta-1 isoform 1 [KO:K02105]
1571  CYP2E1; cytochrome P450 2E1 [KO:K07415] [EC:1.14.14.-]
207  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
208  AKT2; RAC-beta serine/threonine-protein kinase isoform 1 [KO:K04456] [EC:2.7.11.1]
2168  FABP1; fatty acid-binding protein, liver [KO:K08750]
217  ALDH2; aldehyde dehydrogenase, mitochondrial isoform 1 precursor [KO:K00128] [EC:1.2.1.3]
219  ALDH1B1; aldehyde dehydrogenase X, mitochondrial precursor [KO:K00128] [EC:1.2.1.3]
2194  FASN; fatty acid synthase [KO:K00665] [EC:2.3.1.85]
223  ALDH9A1; 4-trimethylaminobutyraldehyde dehydrogenase isoform 1 precursor [KO:K00149] [EC:1.2.1.47 1.2.1.3]
224  ALDH3A2; aldehyde dehydrogenase family 3 member A2 isoform 2 [KO:K00128] [EC:1.2.1.3]
2308  FOXO1; forkhead box protein O1 [KO:K07201]
2309  FOXO3; forkhead box protein O3 isoform 1 [KO:K09408]
23118  TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 isoform a [KO:K04404]
23175  LPIN1; phosphatidate phosphatase LPIN1 isoform 1 [KO:K15728] [EC:3.1.3.4]
23411  SIRT1; NAD-dependent protein deacetylase sirtuin-1 isoform a [KO:K11411] [EC:2.3.1.286]
23417  MLYCD; malonyl-CoA decarboxylase, mitochondrial [KO:K01578] [EC:4.1.1.9]
23643  LY96; lymphocyte antigen 96 isoform 1 precursor [KO:K05400]
23765  IL17RA; interleukin-17 receptor A isoform 1 precursor [KO:K05164]
257397  TAB3; TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 isoform 1 [KO:K12793]
29110  TBK1; serine/threonine-protein kinase TBK1 [KO:K05410] [EC:2.7.11.10]
2919  CXCL1; growth-regulated alpha protein precursor [KO:K05505]
2920  CXCL2; C-X-C motif chemokine 2 precursor [KO:K05505]
2921  CXCL3; C-X-C motif chemokine 3 precursor [KO:K05505]
2932  GSK3B; glycogen synthase kinase-3 beta isoform 2 [KO:K03083] [EC:2.7.11.26]
29896  TRA2A; transformer-2 protein homolog alpha isoform 1 [KO:K12897]
31  ACACA; acetyl-CoA carboxylase 1 isoform 2 [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
32  ACACB; acetyl-CoA carboxylase 2 isoform a [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
34  ACADM; medium-chain specific acyl-CoA dehydrogenase, mitochondrial isoform a precursor [KO:K00249] [EC:1.3.8.7]
3439  IFNA1; interferon alpha-1 precursor [KO:K05414]
3440  IFNA2; interferon alpha-2 precursor [KO:K05414]
3441  IFNA4; interferon alpha-4 precursor [KO:K05414]
3442  IFNA5; interferon alpha-5 precursor [KO:K05414]
3443  IFNA6; interferon alpha-6 precursor [KO:K05414]
3444  IFNA7; interferon alpha-7 precursor [KO:K05414]
3445  IFNA8; interferon alpha-8 precursor [KO:K05414]
3446  IFNA10; interferon alpha-10 precursor [KO:K05414]
3447  IFNA13; interferon alpha-13 precursor [KO:K05414]
3448  IFNA14; interferon alpha-14 precursor [KO:K05414]
3449  IFNA16; interferon alpha-16 precursor [KO:K05414]
3451  IFNA17; interferon alpha-17 precursor [KO:K05414]
3452  IFNA21; interferon alpha-21 precursor [KO:K05414]
3456  IFNB1; interferon beta precursor [KO:K05415]
355  FAS; tumor necrosis factor receptor superfamily member 6 isoform 1 precursor [KO:K04390]
3551  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform 1 [KO:K07209] [EC:2.7.11.10]
3553  IL1B; interleukin-1 beta proprotein [KO:K04519]
356  FASLG; tumor necrosis factor ligand superfamily member 6 isoform 1 [KO:K04389]
3569  IL6; interleukin-6 isoform 1 precursor [KO:K05405]
3576  CXCL8; interleukin-8 isoform 1 precursor [KO:K10030]
3592  IL12A; interleukin-12 subunit alpha isoform 4 precursor [KO:K05406]
3593  IL12B; interleukin-12 subunit beta precursor [KO:K05425]
3605  IL17A; interleukin-17A precursor [KO:K05489]
3654  IRAK1; interleukin-1 receptor-associated kinase 1 isoform 1 [KO:K04730] [EC:2.7.11.1]
3661  IRF3; interferon regulatory factor 3 isoform 1 [KO:K05411]
37  ACADVL; very long-chain specific acyl-CoA dehydrogenase, mitochondrial isoform 1 precursor [KO:K09479] [EC:1.3.8.9]
3929  LBP; lipopolysaccharide-binding protein precursor [KO:K05399]
406999  MIR217; hsa-miR-217-3p [KO:K17125]
4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 isoform 2 [KO:K04426] [EC:2.7.11.25]
4615  MYD88; myeloid differentiation primary response protein MyD88 isoform 2 [KO:K04729]
4790  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform 2 proprotein [KO:K02580]
4792  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
501  ALDH7A1; alpha-aminoadipic semialdehyde dehydrogenase isoform 1 precursor [KO:K14085] [EC:1.2.1.31 1.2.1.8 1.2.1.3]
50507  NOX4; NADPH oxidase 4 isoform a [KO:K21423] [EC:1.6.3.-]
51  ACOX1; peroxisomal acyl-coenzyme A oxidase 1 isoform b [KO:K00232] [EC:1.3.3.6]
51094  ADIPOR1; adiponectin receptor protein 1 [KO:K07297]
51135  IRAK4; interleukin-1 receptor-associated kinase 4 isoform a [KO:K04733] [EC:2.7.11.1]
51176  LEF1; lymphoid enhancer-binding factor 1 isoform 1 [KO:K04492]
51422  PRKAG2; 5'-AMP-activated protein kinase subunit gamma-2 isoform a [KO:K07200]
53632  PRKAG3; 5'-AMP-activated protein kinase subunit gamma-3 [KO:K07200]
5465  PPARA; peroxisome proliferator-activated receptor alpha isoform 1 [KO:K07294]
5562  PRKAA1; 5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform 1 [KO:K07198] [EC:2.7.11.31]
5563  PRKAA2; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [KO:K07198] [EC:2.7.11.31]
5564  PRKAB1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
5565  PRKAB2; 5'-AMP-activated protein kinase subunit beta-2 [KO:K07199]
5571  PRKAG1; 5'-AMP-activated protein kinase subunit gamma-1 isoform 1 [KO:K07200]
5599  MAPK8; mitogen-activated protein kinase 8 isoform alpha2 [KO:K04440] [EC:2.7.11.24]
5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
5601  MAPK9; mitogen-activated protein kinase 9 isoform alpha2 [KO:K04440] [EC:2.7.11.24]
5602  MAPK10; mitogen-activated protein kinase 10 isoform 1 [KO:K04440] [EC:2.7.11.24]
5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
5606  MAP2K3; dual specificity mitogen-activated protein kinase kinase 3 isoform B [KO:K04432] [EC:2.7.12.2]
5608  MAP2K6; dual specificity mitogen-activated protein kinase kinase 6 isoform 1 [KO:K04433] [EC:2.7.12.2]
5609  MAP2K7; dual specificity mitogen-activated protein kinase kinase 7 isoform 3 [KO:K04431] [EC:2.7.12.2]
595  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
5970  RELA; transcription factor p65 isoform 1 [KO:K04735]
6300  MAPK12; mitogen-activated protein kinase 12 isoform 1 [KO:K04441] [EC:2.7.11.24]
6319  SCD; stearoyl-CoA desaturase [KO:K00507] [EC:1.14.19.1]
6416  MAP2K4; dual specificity mitogen-activated protein kinase kinase 4 isoform 1 [KO:K04430] [EC:2.7.12.2]
6434  TRA2B; transformer-2 protein homolog beta isoform 1 [KO:K12897]
64900  LPIN3; phosphatidate phosphatase LPIN3 isoform 2 [KO:K15728] [EC:3.1.3.4]
6720  SREBF1; sterol regulatory element-binding protein 1 isoform 2 [KO:K07197]
6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform B [KO:K04427] [EC:2.7.11.25]
6932  TCF7; transcription factor 7 isoform 1 [KO:K02620]
6934  TCF7L2; transcription factor 7-like 2 isoform 17 [KO:K04491]
7099  TLR4; toll-like receptor 4 isoform A precursor [KO:K10160]
712  C1QA; complement C1q subcomponent subunit A precursor [KO:K03986]
7124  TNF; tumor necrosis factor [KO:K03156]
713  C1QB; complement C1q subcomponent subunit B isoform 1 precursor [KO:K03987]
7132  TNFRSF1A; tumor necrosis factor receptor superfamily member 1A isoform 1 precursor [KO:K03158]
714  C1QC; complement C1q subcomponent subunit C isoform 1 precursor [KO:K03988]
717  C2; complement C2 isoform 1 preproprotein [KO:K01332] [EC:3.4.21.43]
718  C3; complement C3 preproprotein [KO:K03990]
7187  TRAF3; TNF receptor-associated factor 3 isoform 1 [KO:K03174]
7189  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
719  C3AR1; C3a anaphylatoxin chemotactic receptor [KO:K04009]
720  C4A; complement C4-A isoform 1 preproprotein [KO:K03989]
721  C4B; complement C4-B preproprotein [KO:K03989]
727  C5; complement C5 isoform 1 preproprotein [KO:K03994]
728  C5AR1; C5a anaphylatoxin chemotactic receptor 1 [KO:K04010]
79602  ADIPOR2; adiponectin receptor protein 2 isoform 2 [KO:K07297]
79966  SCD5; stearoyl-CoA desaturase 5 isoform a [KO:K00507] [EC:1.14.19.1]
8310  ACOX3; peroxisomal acyl-coenzyme A oxidase 3 isoform a [KO:K00232] [EC:1.3.3.6]
83439  TCF7L1; transcription factor 7-like 1 [KO:K04490]
836  CASP3; caspase-3 isoform a preproprotein [KO:K02187] [EC:3.4.22.56]
841  CASP8; caspase-8 isoform 2 precursor [KO:K04398] [EC:3.4.22.61]
84818  IL17RC; interleukin-17 receptor C isoform 2 precursor [KO:K05166]
8517  IKBKG; NF-kappa-B essential modulator isoform a [KO:K07210]
8717  TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein [KO:K03171]
8737  RIPK1; receptor-interacting serine/threonine-protein kinase 1 isoform 1 [KO:K02861] [EC:2.7.11.1]
8772  FADD; FAS-associated death domain protein [KO:K02373]
9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
929  CD14; monocyte differentiation antigen CD14 precursor [KO:K04391]
9370  ADIPOQ; adiponectin precursor [KO:K07296]
9641  IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform 1 [KO:K07211] [EC:2.7.11.10]
9663  LPIN2; phosphatidate phosphatase LPIN2 [KO:K15728] [EC:3.1.3.4]
Compound
C00003  NAD+
C00005  NADPH
C00006  NADP+
C00024  Acetyl-CoA
C00033  Acetate
C00040  Acyl-CoA
C00076  Calcium cation
C00083  Malonyl-CoA
C00084  Acetaldehyde
C00469  Ethanol
C22381  Reactive oxygen species
Reference
PMID:25782093
  Authors
Louvet A, Mathurin P
  Title
Alcoholic liver disease: mechanisms of injury and targeted treatment.
  Journal
Nat Rev Gastroenterol Hepatol 12:231-42 (2015)
DOI:10.1038/nrgastro.2015.35
Reference
PMID:21920463
  Authors
Gao B, Bataller R
  Title
Alcoholic liver disease: pathogenesis and new therapeutic targets.
  Journal
Gastroenterology 141:1572-85 (2011)
DOI:10.1053/j.gastro.2011.09.002
Reference
PMID:28134813
  Authors
Magdaleno F, Blajszczak CC, Nieto N
  Title
Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.
  Journal
Biomolecules 7:9 (2017)
DOI:10.3390/biom7010009
Reference
PMID:19553649
  Authors
Lucey MR, Mathurin P, Morgan TR
  Title
Alcoholic hepatitis.
  Journal
N Engl J Med 360:2758-69 (2009)
DOI:10.1056/NEJMra0805786
Reference
PMID:26919968
  Authors
Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH
  Title
Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.
  Journal
Gastroenterology 150:1756-68 (2016)
DOI:10.1053/j.gastro.2016.02.035
Reference
PMID:25009376
  Authors
Fujii H, Kawada N
  Title
Fibrogenesis in alcoholic liver disease.
  Journal
World J Gastroenterol 20:8048-54 (2014)
DOI:10.3748/wjg.v20.i25.8048
Reference
PMID:26755857
  Authors
Kim MS, Ong M, Qu X
  Title
Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
  Journal
World J Gastroenterol 22:8-23 (2016)
DOI:10.3748/wjg.v22.i1.8
Reference
PMID:15194557
  Authors
You M, Crabb DW
  Title
Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.
  Journal
Am J Physiol Gastrointest Liver Physiol 287:G1-6 (2004)
DOI:10.1152/ajpgi.00056.2004
Reference
PMID:26695748
  Authors
Nagy LE
  Title
The Role of Innate Immunity in Alcoholic Liver Disease.
  Journal
Alcohol Res 37:237-50 (2015)
Reference
PMID:21252049
  Authors
Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S
  Title
Innate immunity in alcoholic liver disease.
  Journal
Am J Physiol Gastrointest Liver Physiol 300:G516-25 (2011)
DOI:10.1152/ajpgi.00537.2010
Reference
PMID:22524187
  Authors
Wang HJ, Gao B, Zakhari S, Nagy LE
  Title
Inflammation in alcoholic liver disease.
  Journal
Annu Rev Nutr 32:343-68 (2012)
DOI:10.1146/annurev-nutr-072610-145138
Reference
PMID:29597356
  Authors
McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE
  Title
Complement Factor D protects mice from ethanol-induced inflammation and liver injury.
  Journal
Am J Physiol Gastrointest Liver Physiol 315:G66-G79 (2018)
DOI:10.1152/ajpgi.00334.2017
Reference
PMID:24385684
  Authors
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H
  Title
The effect of inflammatory cytokines in alcoholic liver disease.
  Journal
Mediators Inflamm 2013:495156 (2013)
DOI:10.1155/2013/495156
Reference
PMID:20238398
  Authors
Szabo G, Bala S
  Title
Alcoholic liver disease and the gut-liver axis.
  Journal
World J Gastroenterol 16:1321-9 (2010)
DOI:10.3748/wjg.v16.i11.1321
Reference
PMID:28627645
  Authors
Kawaratani H, Moriya K, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Takaya H, Nishimura N, Sato S, Sawada Y, Seki K, Kubo T, Mitoro A, Yamao J, Yoshiji H
  Title
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
  Journal
Int J Mol Med 40:263-270 (2017)
DOI:10.3892/ijmm.2017.3015
Reference
PMID:23855294
  Authors
Roh YS, Seki E
  Title
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
  Journal
J Gastroenterol Hepatol 28 Suppl 1:38-42 (2013)
DOI:10.1111/jgh.12019
Reference
PMID:18709650
  Authors
Rogers CQ, Ajmo JM, You M
  Title
Adiponectin and alcoholic fatty liver disease.
  Journal
IUBMB Life 60:790-7 (2008)
DOI:10.1002/iub.124
Reference
PMID:26278388
  Authors
You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P
  Title
Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
  Journal
Curr Mol Pharmacol 10:226-236 (2017)
DOI:10.2174/1874467208666150817112109
Reference
PMID:26005675
  Authors
You M, Jogasuria A, Taylor C, Wu J
  Title
Sirtuin 1 signaling and alcoholic fatty liver disease.
  Journal
Hepatobiliary Surg Nutr 4:88-100 (2015)
DOI:10.3978/j.issn.2304-3881.2014.12.06
Reference
PMID:33162823
  Authors
Ren R, Wang Z, Wu M, Wang H
  Title
Emerging Roles of SIRT1 in Alcoholic Liver Disease.
  Journal
Int J Biol Sci 16:3174-3183 (2020)
DOI:10.7150/ijbs.49535
Reference
PMID:19032584
  Authors
Purohit V, Gao B, Song BJ
  Title
Molecular mechanisms of alcoholic fatty liver.
  Journal
Alcohol Clin Exp Res 33:191-205 (2009)
DOI:10.1111/j.1530-0277.2008.00827.x
Reference
PMID:34071962
  Authors
Hyun J, Han J, Lee C, Yoon M, Jung Y
  Title
Pathophysiological Aspects of Alcohol Metabolism in the Liver.
  Journal
Int J Mol Sci 22:5717 (2021)
DOI:10.3390/ijms22115717
Reference
PMID:24297186
  Authors
Combs TP, Marliss EB
  Title
Adiponectin signaling in the liver.
  Journal
Rev Endocr Metab Disord 15:137-47 (2014)
DOI:10.1007/s11154-013-9280-6
Reference
PMID:25548474
  Authors
Ceni E, Mello T, Galli A
  Title
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
  Journal
World J Gastroenterol 20:17756-72 (2014)
DOI:10.3748/wjg.v20.i47.17756
Reference
PMID:31159489
  Authors
Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T
  Title
Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
  Journal
Int J Mol Sci 20:E2712 (2019)
DOI:10.3390/ijms20112712
Reference
PMID:31214376
  Authors
Ohashi K, Pimienta M, Seki E
  Title
Alcoholic liver disease: A current molecular and clinical perspective.
  Journal
Liver Res 2:161-172 (2018)
DOI:10.1016/j.livres.2018.11.002
Reference
PMID:30658725
  Authors
You M, Arteel GE
  Title
Effect of ethanol on lipid metabolism.
  Journal
J Hepatol 70:237-248 (2019)
DOI:10.1016/j.jhep.2018.10.037
Reference
PMID:25595739
  Authors
Bi L, Jiang Z, Zhou J
  Title
The role of lipin-1 in the pathogenesis of alcoholic fatty liver.
  Journal
Alcohol Alcohol 50:146-51 (2015)
DOI:10.1093/alcalc/agu102
Reference
PMID:31263795
  Authors
Ali H, Assiri MA, Shearn CT, Fritz KS
  Title
Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.
  Journal
Curr Opin Toxicol 13:110-117 (2019)
DOI:10.1016/j.cotox.2018.10.003
Reference
PMID:24262277
  Authors
Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens SM Jr, You M
  Title
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
  Journal
Gastroenterology 146:801-11 (2014)
DOI:10.1053/j.gastro.2013.11.008
Reference
PMID:22110053
  Authors
Stickel F, Hampe J
  Title
Genetic determinants of alcoholic liver disease.
  Journal
Gut 61:150-9 (2012)
DOI:10.1136/gutjnl-2011-301239
Reference
PMID:29336467
  Authors
Yang CF, Zhong YJ, Ma Z, Li L, Shi L, Chen L, Li C, Wu D, Chen Q, Li YW
  Title
NOX4/ROS mediate ethanolinduced apoptosis via MAPK signal pathway in L02 cells.
  Journal
Int J Mol Med 41:2306-2316 (2018)
DOI:10.3892/ijmm.2018.3390
Related
pathway
hsa00061  Fatty acid biosynthesis
hsa00071  Fatty acid degradation
hsa01040  Biosynthesis of unsaturated fatty acids
hsa03040  Spliceosome
hsa04010  MAPK signaling pathway
hsa04064  NF-kappa B signaling pathway
hsa04152  AMPK signaling pathway
hsa04210  Apoptosis
hsa04310  Wnt signaling pathway
hsa04610  Complement and coagulation cascades
hsa04620  Toll-like receptor signaling pathway
hsa04657  IL-17 signaling pathway
hsa04668  TNF signaling pathway
hsa04920  Adipocytokine signaling pathway
hsa05034  Alcoholism
hsa05225  Hepatocellular carcinoma
KO pathway
ko04936   

  All links  
No link information was found.
DBGET integrated database retrieval system